Analysis of domestic mitotane price range and fluctuation factors

Mitotane is one of the core drugs currently used to treat adrenocortical cancer (Adrenocortical Carcinoma, ACC) and has unique application value. Its main mechanism is to achieve anti-tumor effects by selectively destroying adrenocortical cells and inhibiting hormone synthesis. Mitotane is often used in patients with unresectable locally advanced or metastatic ACC and can also be used as postoperative adjuvant therapy to reduce the risk of disease recurrence.

Since mitotane needs to reach a certain plasma concentration in the body (generally 14-20 mg/L) to achieve optimal efficacy, blood levels need to be closely monitored and the dosage adjusted during treatment. At the same time, in order to cope with hormone deficiency caused by suppression of adrenal function, patients often require long-term supplementary hormone replacement therapy. Mitotane has a slow onset of action and a long-lasting effect, but the management of side effects is also particularly critical, including gastrointestinal discomfort, nervous system reactions, and metabolic disorders.

Regarding the price of mitotane in China, due to the short introduction time of the original drug, the price has not yet been announced uniformly, and it has not yet been included in the scope of medical insurance reimbursement. Patients need to purchase it at their own expense. For specific costs, please consult designated medical institutions or authorized pharmacies. In the international market, the original version of mitotane is available in European and Turkish versions. The common specifications are 500mg 100 tablets/box, and the price is about 9,000 yuan. However, with changes in the RMB exchange rate and fluctuations in supply and demand in the international market, the actual purchase price may fluctuate up or down. In addition, some mitotane generic drugs are currently available in overseas markets. For example, products of the same specification produced in Laos are priced in the range of RMB 2,000-3,000, which is much lower than the original drug. However, attention must be paid to drug quality and efficacy during clinical application.

Overall, mitotane price fluctuations are mainly affected by factors such as exchange rate changes, import channels, supply chain stability, and national policy adjustments. When purchasing, patients are advised to choose formal channels and use them under the guidance of professional doctors to ensure treatment effects and medication safety.

Reference materials:https://go.drugbank.com/drugs/DB00648